CHRISTINE CAMPBELL: Open Payments
NPI 1174175608 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 22 payments from 17 companies in 2025. Trend: 2023 $548 · 2024 $874 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 3 | $70 |
| Gilead Sciences, Inc. | 2 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| PharmaEssentia USA Corporation | 2 | $44 |
| TAIHO ONCOLOGY, INC. | 1 | $29 |
| Incyte Corporation | 1 | $26 |
| Eisai Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Acrotech Biopharma Inc. | 1 | $23 |
Products named: Trodelvy, REBLOZYL, Nubeqa, BESREMI, OPDIVO, LONSURF, MONJUVI, Lenvima.
Industry payments across SC — which companies pay providers there.
